Keyword Connections

hcv

Journals

18

1 Bioorganic & medicinal chemistry letters

2 BMC infectious diseases

3 Microbial pathogenesis

4 ophthalmology

5 journal of hepatology

6 african health sciences

7 aids care

8 mmwr morbidity and mortality weekly report

9 developing world bioethics

10 aids patient care and stds

11 journal of health, population, and nutrition

12 journal de gynecologie, obstetrique et biologie de la reproduction

13 The American journal of Chinese medicine

14 Current HIV Research

15 current opinion in hiv and aids

16 jhep reports (online)

17 aids policy & law

18 positively aware : the monthly journal of the test positive aware network

Research Groups

0

No Research Group Connected

Bibliographies

129

1 Characterization of the hepatitis C virus epidemic in Pakistan.

2 Discovery of a novel unsymmetrical structural class of HCV NS5A inhibitors with low picomolar antiviral activity.

3 Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery.

4 Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.

5 Liver fibrosis and CD206 macrophage accumulation are suppressed by anti-GM-CSF therapy.

6 Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus.

7 Rapid screening for co-infection of HIV and HCV in pregnant women in Benin City, Edo State, Nigeria.

8 Clinical pharmacology of HIV protease inhibitors in pregnancy.

9 Provider-initiated HIV testing and counseling in health facilities--what does this mean for the health and human rights of pregnant women?

10 An approach to addressing ethical issues in a community-based risk assessment for HIV: a case from Chennai, India.

11 Introduction of routine HIV testing in prenatal care--Botswana, 2004.

12 Mother-to-child transmission of HIV infection and its prevention.

13 Women's acceptability and husband's support of rapid HIV testing of pregnant women in India.

14 Panel urges universal testing of pregnant women for HIV.

15 She's having a baby?

16 Concerns of pregnant women about bing tested for HIV: a study in a predominately Mexican-American population.

17 [Knowledge and behavior of pregnant women towards HIV infection and its screening].

18 dsrna-dependent protein kinase pkr and its role in stress, signaling and hcv infection

19 hiv and hcv coinfection: prevalence, associated factors and genotype characterization in the midwest region of brazil

20 telaprevir or boceprevir for hepatitis c treatment: a first survey of pharmacoutilization

21 current level of evidence on causal association between hepatitis c virus and type 2 diabetes: a review

22 carpal tunnel syndrome in hiv-positive patients coinfected with hcv

23 the humoral immune response to hcv: understanding is key to vaccine development

24 demethylase jmjd6 as a new regulator of interferon signaling: effects of hcv and ethanol metabolism

25 اثر ایندومتاسین در کاهش حجم مایع آمنیوتیک در پلی هیدرآمنیوس متوسط و شدید

26 hemodialysis patients treated for hepatitis c using a sofosbuvir-based regimen

27 type i interferon regulates the expression of long noncoding rnas

28 influence of hiv and hcv on t cell antigen presentation and challenges in the development of vaccines

29 esteato-hepatite relacionada ao vírus da hepatite c: perfil clínico-histológico steatohepatitis related to hepatitis c virus: clinical and histological profiles

30 recombinant hepatitis c virus-envelope protein 2 interactions with low-density lipoprotein/cd81 receptors

31 exploitation of lipid components by viral and host proteins for hepatitis c virus infection

32 patients with haemoglobinopathies and chronic hepatitis c: a really difficult to treat population in 2016?

33 the 5bsl3.2 functional rna domain connects distant regions in the hepatitis c virus genome

34 perinatal transmission of hepatitis viruses: the possible mechanisms

35 nk cell function and receptor diversity in the context of hcv infection

36 Structural and compositional segregation of the gut microbiota in HCV and liver cirrhotic patients: A clinical pilot study.

37 Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization

38 Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations

39 Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype

40 Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial

41 Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities

42 Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients

43 Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations

44 Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations

45 Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype

46 Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial

47 Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities

48 Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients

49 Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication.

50 The new Xpert HCV viral load real-time PCR assay accurately quantifies hepatitis C virus RNA in serum and whole-blood specimens

51 Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV&ndash;HCV coinfected patients

52 Prevalence of mixed hepatitis C virus (HCV) genotypes among recently diagnosed dialysis patients with HCV infection

53 Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.

54 Cognitive impairments in HCV infection: From pathogenesis to neuroimaging.

55 Elevated fatty liver index as a risk factor for all-cause mortality in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study).

56 Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study

57 A Framework for Prediction of Response to HCV Therapy Using Different Data Mining Techniques

58 Temporal Changes and Regional Variation in Acceptance of HCV-viremic Livers.

59 Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.

60 Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.

61 New Insights into the Rational Use of HCV+ Organs Worldwide.

62 A systematic review on high conservation value assessment (HCVs): Challenges and framework for future research on conservation strategy.

63 Improving the aqueous solubility of HCV-E2 glycoprotein epitope mimics by cyclization using POLAR hinges.

64 HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?

65 FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.

66 The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK.

67 Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients

68 Evaluation of biochemical, hematological, RIBA and PCR assays in predicting viremia in anti-HCV positive patients.

69 Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy.

70 Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection

71 Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

72 HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation

73 The Immunogenicity in Mice of HCV Core Delivered as DNA Is Modulated by Its Capacity to Induce Oxidative Stress and Oxidative Stress Response

74 Immuno-MALDI MS dataset for improved detection of HCVcoreAg in sera

75 A Call to Action: HCV Treatment of People Who Inject Drugs in the United States

76 What is required for achieving HCV elimination in Singapore? A modeling study

77 Hepatitis C (HCV) microelimination in HIV-coinfected men who have sex with men (MSM): A low hanging fruit?

78 Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors

79 Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services

80 HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection

81 Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services

82 Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors

83 Boceprevir for untreated chronic HCV genotype 1 infection

84 anti-hcv prevalence and risk factors analysis in pregnant women in central brazil

85 hepatitis c virus (hcv): prevalence in a gynecological urgent care clinic population

86 monitoring of therapy in patients with hiv/hcv co-infection who receive antiviral therapy against hepatitis c and antiretroviral therapy

87 glances in immunology of hiv and hcv infection

88 survey of both hepatitis b virus (hbsag) and hepatitis c virus (hcv-ab) coinfection among hiv positive patients

89 on-treatment elevation in hepatic transaminases during hcv treatment with ombitasvir, paritaprevir, dasabuvir, ritonavir, and ribavirin: a case series

90 an update on small molecule inhibitors of the hcv ns5b polymerase: effects on rna synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies

91 hepatocyte turnover in chronic hcv-induced liver injury and cirrhosis

92 parv4 prevalence, phylogeny, immunology and coinfection with hiv, hbv and hcv in a multicentre african cohort [version 1; referees: 2 approved]

93 mechanism of hcv's resistance to ifn-α in cell culture involves expression of functional ifn-α receptor 1

94 are hiv, hbv and hcv voluntary counseling and testing programs needed in balkans?

95 a new sampling method for spleen stiffness measurement based on quantitative acoustic radiation force impulse elastography for noninvasive assessment of esophageal varices in newly diagnosed hcv-related cirrhosis

96 analysis of association between different hcv genotypes and serum interleukin-17, interleukin-6, and vitamin d in patients with hcv-related cirrhosis

97 neutralizing activities of caprine antibodies towards conserved regions of the hcv envelope glycoprotein e2

98 evaluation of the therapeutic response of hepatitis c in coinfected patients (hiv/hcv): a study of cases from a hospital for chronic liver diseases in the eastern brazilian amazon

99 hgv-hcv/hbv co-infection in india: a pilot study

100 liver damage in patients with hcv/hiv coinfection is linked to hiv-related oxidative stress

101 different culture metabolites of the red sea fungus fusarium equiseti optimize the inhibition of hepatitis c virus ns3/4a protease (hcv pr)